Study of novel 1,4-dihydropyridine derivatives as prospective anti-inflammatory remedies: a randomised controlled trial

Background. Over the past decades, scientific community is motivated on finding new anti-inflammatory agents with a safe and high-effective profile to manage pathology.

Objectives. A study of the anti-inflammatory action of novel compounds, 1,4-dihydropyridine derivatives, in a classical formalin-induced paw oedema test in white rats.

Methods. Originally synthesised 1,4-dihydropyridine derivatives were preliminarily subjected to virtual screening using the SwissTargetPrediction toolkit. White laboratory rats (130 animals) were divided into a control (formalin oedema) and intact group, 4 comparison (meloxicam, sodium metamizole, sodium diclofenac and indomethacin) and 7 experiment groups by the number of 1,4-dihydropyridine derivatives studied. The samples anti-inflammatory efficacy was evaluated in acute formalin-induced paw oedema model simulated by right hind limb subplantar injection of 0.1 mL 2% formalin. The studied substances were administered intragastrically at 5 mg/kg 1.5 h prior to oedema induction. Oncometry was assessed quantitatively by limb circumference. Animals were managed in compliance with GOST 33044–2014 “Principles of Good Laboratory Practice” at all experiment steps. Experimental data were analysed statistically to describe quantitative variability with variance σ2, mean limb girth a and standard deviation σ. Data homogeneity and reliability were estimated by variation coefficient V and the Wilcoxon T(W) criterion.

Results. As the most anti-inflammatory effective, partially hydrogenated mar-040 pyridines (ethyl 4-({[5-cyano-6-{[2-(diphenylamino)-2-oxoethyl]thio}-4-(2-furyl)-2-methyl-1,4-dihydropyridin-3-yl]carbonyl}amino) benzoate) were shown 33-fold superior to indomethacin, 26-fold — to sodium diclofenac, 25-fold — to meloxicam and 30-fold — to sodium metamizole; mar-037 pyridines (ethyl 4-[({[3-cyano-5-({[4-(ethoxycarbonyl)phenyl]amino}carbonyl)-4-(2-furyl)-6-methyl-1,4-dihydropyridin-2-yl]thio}acetyl)amino] benzoate) — 17–23-fold superior vs. reference drugs. We also show that mаr-014 (ethyl 4-({[5-cyano-6-({2-[(3,5-dichlorophenyl) amino]-2-oxoethyl}thio)-4-(2-furyl)-2-methyl-1,4-dihydropyridin-3-yl]carbonyl}amino)benzoate) and mar033 (ethyl 2-[({[3-cyano-5-({[4-(ethoxycarbonyl)phenyl]amino}carbonyl)-4-(2-furyl)-6-methyl-1,4-dihydropyridin-2-yl]thio}acetyl)amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate) compounds are 2.7-fold more effective vs. reference drugs.

Conclusion. The synthesised 1,4-dihydropyridine compounds reveal high efficacy in experimental assays. Selected novel 1,4-dihydropyridine derivatives exhibit a marked anti-inflammatory activity and offer value in future preclinical trials.

1. Alekseeva L.I., Kovalenko P.S. Meloxicam in rheumatology practice: The history of its use in the therapy of pain. Modern Rheumatology Journal. 2016; 10(2): 50-55 (In Russ., English abstract). DOI: 10.14412/1996-7012-2016-2-50-55

2. Clinical guidelines «Rational use of nonsteroidal anti-inflammatory drugs (NSAIDs) in clinical practice». Part I. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2015; 115(4): 70–82 (In Russ.). DOI: 10.17116/jnevro20151154170-82

3. Dyadyk A.I., Kugler T.E. Side effects of non-steroidal anti-inflammatory drugs. Consilium Medicum. 2017; 19(12): 94–99 (In Russ., English abstract). DOI: 10.26442/2075-1753_19.12.94-99

4. Kostina I. N., Ognev M. Yu. The use of nsaids of different chemical structure for the treatment of postoperative pain: a randomized prospective clinical study. The Actual Problems in Dentistry. 2017; 13(2): 45–48 (In Russ., English abstract). DOI: 10.18481/2077-7566-2017-13-2-45-48

5. Lesnaya O.A., Rusanova E.I., Prokofieva E.B., Freire Da Silva T. Rational use of NSAIDS according to clinical guidelines and data from recent studies. Trudnyi Patsient. 2019; 17(10): 31–34 (In Russ., English abstract). DOI: 10.24411/2074-1995-2019-10072

6. Larsen I.M., Drewes A.M., Olesen A.E. The Effect of a Combination of Diclofenac and Methadone Applied as Gel in a Human Experimental Pain Model — A Randomized, Placebo-controlled Trial. Basic Clin. Pharmacol. Toxicol. 2018; 123(2): 188–194. DOI: 10.1111/bcpt.12993

7. Schmidt M., Sørensen H.T., Pedersen L. Diclofenac use and cardiovascular risks: series of nationwide cohort studies. BMJ. 2018; 362: k3426. DOI: 10.1136/bmj.k3426

8. Nozadze I., Tsiklauri N., Gurtskaia G., Tsagareli M.G. NSAIDs attenuate hyperalgesia induced by TRP channel activation. Data. Brief. 2016; 6: 668–673. DOI: 10.1016/j.dib.2015.12.055

9. Stevens J.P., Wall M.J., Novack L., Marshall J., Hsu D.J., Howell M.D. The Critical Care Crisis of Opioid Overdoses in the United States. Ann. Am. Thorac. Soc. 2017; 14(12): 1803–1809. DOI: 10.1513/AnnalsATS.201701-022OC

10. Sepehri S., Sanchez H.P., Fassihi A. Hantzsch-Type dihydropyridines and Biginelli-type tetra-hydropyrimidines: a review of their chemotherapeutic activities. J. Pharm. Pharm. Sci. 2015; 18(1): 1–52. DOI: 10.18433/j3q01v

11. Khan M.M., Khan S., Saigal S., Iqbal S. Recent developments in multicomponent synthesis of structurally diversified tetrahydropyridines. RSC Advances [Internet]. Royal Society of Chemistry (RSC). 2016; 6(48): 42045–42061. DOI: 10.1039/c6ra06767k

12. Khot S., Auti P.B., Khedkar S.A. Diversified Synthetic Pathway of 1, 4-Dihydropyridines: A Class of Pharmacologically Important Molecules. Mini Rev. Med. Chem. 2021; 21(2): 135–149. DOI: 10.2174/1389557520666200807130215

13. Gouda M.A., Hussein B.H.M., Helal M.H., Salem M.A. A Review: Synthesis and Medicinal Importance of Nicotinonitriles and Their Analogous. Journal of Heterocyclic Chemistry. 2018; 55(7): 1524–1553. DOI: 10.1002/jhet.3188

14. Shamroukh A., Kotb E., Anwar M., Sharaf M. A Review on The Chemistry of Nicotinonitriles and Their applications. Egyptian Journal of Chemistry. 2021; 64(8) : 33. DOI: 10.21608/ejchem.2021.64971.3392

15. Salem M.A., Helel M.H., Gouda M.A., Ammar Y.A., El-Gaby M.S.A. Overview on the synthetic routes to nicotine nitriles. Synthetic Communications. 2018; 48(4); 345. DOI: 10.1080/00397911.2017.1394468

16. Osolodkin D.I., Kozlovskaya L.I., Dueva E.V., Dotsenko V.V., Rogova Y.V., Frolov K.A., Krivokolysko S.G., Romanova E.G., Morozov A.S., Karganova G.G., Palyulin V.A., Pentkovski V.M., Zefirov N.S. Inhibitors of tick-borne flavivirus reproduction from structure-based virtual screening. ACS Med. Chem. Lett. 2013; 4(9): 869–874. DOI: 10.1021/ml400226s

17. Bibik E.Y., Yaroshevskaya O.G., Devdera A.V., Demenko A.V., Zakharov V.V., Frolov K.A., Krivokolysko S.G., Dotsenko V.V. Search for anti-inflammatory agents in the tetrahydropyrido[2,1-B][1,3,5]-thiadiazine series. Pharmaceutical Chemistry Journal. 2017; 51(8): 648–651. DOI: 10.1007/s11094-017-1669-1

18. Bibik E.Yu.1, Saphonova A.A., Yeryomin A.V., Frolov K.A., Dotsenko V.V., Krivokolysko S.G. Study of analeptic activity of tetrahydropyrido [2,1-B] [1,3,5] tiadiazine derivatives. Research Result: Pharmacology and Clinical Pharmacology. 2017; 3(4): 20–25. DOI: 10.18413/2313-8971-2017-3-4-20-25

19. Bibik E.Yu., Nekrasa I.A., Demenko A.V., Frolov K.A., Dotsenko V.V., Krivokolysko S.G. Studying the adaptogenic activity of a series of tetrahydropyrido[2,1-b] [1,3,5] thiadiazine derivatives. Bulletin of Siberian Medicine. 2019; 18(3): 21–28 (In Russ., English abstract). DOI: 10.20538/1682-0363-2019-3-21-28

20. Li X.D., Liu L., Cheng L. Identification of thienopyridine carboxamides as selective binders of HIV-1 trans Activation Response (TAR) and Rev Response Element (RRE) RNAs. Org. Biomol. Chem. 2018; 16(47): 9191–9196. DOI: 10.1039/c8ob02753f

21. Norman D.D., Ibezim A., Scott W.E., White S., Parrill A.L., Baker D.L. Autotaxin inhibition: development and application of computational tools to identify site-selective lead compounds. Bioorg. Med. Chem. 2013; 21(17): 5548–5560. DOI: 10.1016/j.bmc.2013.05.061

22. Sanad S.M.H., Mekky A.E.M. Novel nicotinonitrile-coumarin hybrids as potential acetylcholinesterase inhibitors: design, synthesis, in vitro and in silico studies. Journal of the Iranian Chemical Society. 2020; 18(1): 213–224. DOI: 10.1007/s13738-020-02018-6

23. Gfeller D., Michielin O., Zoete V. Shaping the interaction landscape of bioactive molecules. Bioinformatics. 2013; 29(23): 3073–3079. DOI: 10.1093/bioinformatics/btt540

24. Bibik I.V., Bibik E.Y., Dotsenko V.V., Frolov K.A., Krivokolysko S.G., Aksenov N.A., Aksenova I.V., Shcherbakov S.V., Ovcharov S.N. Synthesis and analgesic activity of new heterocyclic cyanothioacetamide derivatives. Russian Journal of General Chemistry. 2021; 9(2): 154–166. DOI: 10.1134/S107036322102002X

25. Narkevich A.N., Vinogradov K.A. Methods for determining the minimum required sample size in medical research. Social aspects of population health. 2019; 65(6): 10 (In Russ., English abstract). DOI: 10.21045/2071-5021-2019-65-6-10